Skip to main content
Sign In

Geza Bodor, MD​

Professor; Director of University of Colorado Hospital Toxicology and TDM Laboratory


  • MD, Semmelweis University, Budapest, Hungary (1978)

Postdoctoral Education:

  • Resident and Fellow in Clinical Pathology Washington University and Barnes Hospital, St. Louis, MO (1992)

 Research Activities:

  • Development of first monoclonal antibody-based immunoassay for cardiac troponin measurement
  • Experimental and clinical studies of cardiac markers
  • International standardization of cardiac troponin I assay
  • Vitamin D assay development using LCMSMS instrument
  • Forensic toxicology assay development using LCMSMS
  • Laboratory test utilization, laboratory cost containment​

Selected Publications:

  • Bodor GS. Quantitative, Multidrug Pain Medication Testing by Liquid Chromatography – Tandem Mass Spectrometry (LC-MSMS); Published in Methods in Molecular Biology, Vol. 1383, Uttam Garg (Eds): Clinical Applications of Mass Spectrometry in Drug Analysis, USBN 978-1-4939-3251-1, Springer, 2015 Dec
  • Bodor GS, Porter S, Landt Y, Ladenson JH. The Development of Monoclonal Antibodies and an Assay for Cardiac Troponin-I with Preliminary Results in Suspected Myocardial Infarction. Clin Chem 1992​
  • Adams JE, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS. Cardiac Troponin-I: a Marker with High Specificity for Cardiac Injury. Circulation 1993
  • Bodor GS, Porterfield D, Voss E, Survant L, Smith S, Apple FS. Cardiac troponin-T composition in normal and regenerating human skeletal muscle. Clin Chem 1997
  • Christenson RH, Duh SH, Apple FS, Bodor GS, Bunk DM, Dalluge J, Panteghini M, Potter JD, Welch MJ, Wu AH, Kahn SE. Standardization of Cardiac Troponin I Assays: Round Robin of Ten Candidate Reference Materials. Clin Chem 2001